Literature DB >> 18481104

Renal impairment and hydronephrosis in a premature infant following morphine infusion: case report.

Mohammad Khassawneh1, Hassan Al-Balas.   

Abstract

This is a case report of an association between morphine administration and occurrence of hydronephrosis with acute renal failure. This premature female infant born at 27 weeks of gestation had moderate hydronephrosis with acute renal impairment while receiving morphine infusion for pain management after chest-tube insertion. All these findings were reversed after stopping morphine and urinary catheterization. Follow-up renal ultrasound and voiding cystourethrogram showed resolution of hydronephrosis with no evidence of vesicoureteral reflux. Morphine is associated with reversible hydronephrosis and renal impairment in premature infants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481104     DOI: 10.1007/s00467-008-0866-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants.

Authors:  E Saarenmaa; P J Neuvonen; V Fellman
Journal:  J Pediatr       Date:  2000-06       Impact factor: 4.406

2.  Minimal handling protocol for the intensive care nursery.

Authors:  V S Langer
Journal:  Neonatal Netw       Date:  1990-10

Review 3.  Clinical importance of pain and stress in preterm neonates.

Authors:  K J Anand
Journal:  Biol Neonate       Date:  1998

4.  Urinary effects of morphine in preterm infants.

Authors:  B O S Bengtsson; S L Wootton-Gorges; F R Poulain; M P Sherman
Journal:  Acta Paediatr       Date:  2003       Impact factor: 2.299

5.  Bladder retention of urine as a result of continuous intravenous infusion of fentanyl: 2 case reports.

Authors:  U G Das; P Sasidharan
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

6.  Morphine administration and short-term pulmonary outcomes among ventilated preterm infants.

Authors:  Vineet Bhandari; Lena L Bergqvist; Shari S Kronsberg; Bruce A Barton; Kanwaljeet J S Anand
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

7.  Spinal opioid receptors and inhibition of urinary bladder motility in vivo.

Authors:  A Dray; R Metsch
Journal:  Neurosci Lett       Date:  1984-06-01       Impact factor: 3.046

8.  Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism.

Authors:  Nancy J Bouwmeester; Wim C J Hop; Monique van Dijk; K J S Anand; John N van den Anker; Dick Tibboel
Journal:  Intensive Care Med       Date:  2003-07-25       Impact factor: 17.440

9.  Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants.

Authors:  N J Bouwmeester; J N van den Anker; W C J Hop; K J S Anand; D Tibboel
Journal:  Br J Anaesth       Date:  2003-05       Impact factor: 9.166

10.  Neurobehavior of preterm infants at 36 weeks postconception as a function of morphine analgesia.

Authors:  Rakesh Rao; Jackie S Sampers; Shari S Kronsberg; Josephine V Brown; Nirmala S Desai; K J S Anand
Journal:  Am J Perinatol       Date:  2007-09-28       Impact factor: 1.862

  10 in total
  3 in total

1.  Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine.

Authors:  Laura Pogliani; Chiara Mameli; Dario Cattaneo; Emilio Clementi; Fabio Meneghin; Sonia Radice; Simona Bruno; Gian Vincenzo Zuccotti
Journal:  Clin Kidney J       Date:  2012-09-06

Review 2.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

3.  A review on renal toxicity profile of common abusive drugs.

Authors:  Varun Parkash Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.